Evaluation of Safety & Tolerability of Multiple Dose Regimens of CHF 5074

Clinical trial NCT01303744 · COMPLETED

Trial details

NCT number: NCT01303744
Sponsor: CERESPIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2011-03-01
Primary completion: 2012-04-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.